Akèy › Hidradénite suppurative › Kalifòni
Etid klinik pou Hidradénite suppurative nan Kalifòni
12 etid pou Hidradénite suppurative ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Ctr for Dermatology Clinical Res, Fremont
- USC Keck School of Medicine, Los Angeles
- Olive View UCLA Medical Center, Sylmar
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Fountain Valley
- Oruka Therapeutics Investigative Site, Los Angeles
Ap rekriteFaz 2
Laj 18 a 79 · Tout sèks · Mizajou Sep 24, 2026 · NCT07783542A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 105, Santa Monica
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Sep 18, 2026 · NCT06888193Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US076, Fountain Valley
- Investigative Site US077, Fremont
- Investigative Site US071, Huntington Beach
- ak 10 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06855498Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Amicis Research Center Valencia, Northridge
- Children'S Hospital of Orange County, Orange
- Clinical Trials Research Institute, Thousand Oaks
Ap rekriteFaz 1
Laj 12 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07049575Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- Northridge Clinical Trials - Northridge- Site Number : 8400005, Northridge
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07170917Clinical and Biological Characteristics of Hidradenitis Suppurativa
- University of California, San Francisco, San Francisco
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 13 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT03967600Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
- University of California San Francisco, San Francisco
Ap rekriteEtid obsèvasyon
Laj 10 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT04115566A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- UCSF Medical Center, San Francisco
- Stanford Medical Center, Stanford
Ap rekriteEtid obsèvasyon
Laj 18 a 71 · Tout sèks · Mizajou Apr 16, 2026 · NCT07123038A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- First OC Dermatology Research, Fountain Valley
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 6, 2026 · NCT072442631726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)
- Wynn Medical Center Rheumatology/Dermatology, Rosemead
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Sep 17, 2025 · NCT07155239A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- Physioseq, LLC /ID# 267266, Sacramento
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Jan 24, 2025 · NCT06524635Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.